Effects of Fenofibric Acid on Diabetic Macular Edema: The MacuFen study (Q58384543)

1

0 references

Jean-Claude Ansquer

3

0 references

Patrick Aubonnet

4

0 references

for the MacuFEN Study Investigators

Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema

5

0 references

publication date

18 August 2014

0 references

published in

Ophthalmic Epidemiology

0 references

volume

21

0 references

issue

5

0 references

page(s)

307-317

0 references

cites work

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Oral protein kinase c β inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C β I

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Advances in the medical treatment of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Effects of medical therapies on retinopathy progression in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Fibrates and Statins in the Treatment of Diabetic Retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Reproducibility of retinal mapping using optical coherence tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Oral minocycline for the treatment of diabetic macular edema (DME): results of a phase I/II clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Critical appraisal of ranibizumab in the treatment of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783

Emerging pharmacotherapies for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/09286586.2014.949783